Test Bank For Lippincott Illustrated Reviews: Pharmacology 8th Edition by
a1 a1 a1 a1 a1 a1 a1 a1 a1
a1 Karen Whalen||ISBN NO:10,1975170555||ISBN NO:13,978-
a1 a1 a1
1975170554||Chapter 1-48||Complete Guide A+.
a1 a1 a1
hp 1
,
,3. The a 1 a 1 h p nurse a1 a1hp is a 1 a 1 h p teaching a1 a1hp a a1 a1hp patient a 1 a 1 h p who a1 a1hp will a1 a1hp be a1 a1hp discharged a 1
a 1 h p home a1 a1hp with a a1 a1hp a1 a1hp prescription a1 a1hp for a1 a1hp an a1 a1hp enteric- a 1 a 1 h p coated a 1 a 1 h p tablet. a 1
a 1 h p Which a 1 a 1 h p statement a 1 a 1 h p by a1 a1hp the a 1 a 1 h p patient indicates a 1 a 1 h p understanding a 1
a 1 h p of a 1 a 1 h p the a1 a1hp teaching?
a. I may y7crush the tablet
a1 a1hp a1 a1hp a1 a1hp a 1 a 1 h p and a 1 a 1 h p put a 1 a 1 h p it a 1 a 1 h p in applesauce
a1 a1hp a1 a1hp to a1
improve
a1hp absorption. a1 a1hp
b. I a 1 a 1 h p should consume a 1 a 1 h p a 1 a 1 hp acidic a 1 a 1 h p foods to y7 a 1 a 1 h p enhance a1 a1hp absorption a 1 a 1 h p of a1
a1hp this a1 a1hpmedication.
c. I a 1 should
a 1 h p a 1 a 1 h p expect a 1 a 1 h p a a 1 a 1 h p delay a 1 a 1 h p in onset
a 1 a 1 h p a 1 a 1 h p of a 1 a 1 h p the a 1
a 1 h p drugs effects a 1 a 1 h p a 1 after
a 1 h p a 1 a 1 h p taking a 1 the
a 1 h p a 1 a 1 h p tablet.
d. I should
a1 a1hp a 1 a 1 h p take this medication with high-fat
a1 a1hp a1 a1hp a 1 a 1 h p a1 a1hp a 1
a 1 h p foods to a1a1hp a 1 a 1 hp improve its action. ANS: C a1 a1hp a1 a1hp a 1 a 1 h p a 1 a 1 h p
Enteric-coated a 1 a 1 h p tablets a 1 a 1 h p resist a 1 a 1 h p disintegration a 1 a 1 h p in a 1 a 1 h p the a 1 a 1 h p acidic a 1
a 1 h p environment a 1 a 1 h p of a 1 a 1 h p the a 1 a 1 h p stomach a 1 a 1 h p and a1 a1hp disintegrate a1 a1hp when a1 a1hp they a1
a1hp reach a1 a1hp the a1 a1hp small a 1 a 1 h p intestine. a1 a1hp There a 1 a 1 h p is a 1 a 1 h p usually a 1 a 1 h p some a 1 a 1 h p delay a1
a1hp in a1 a1hp onset a 1 a 1 h p of a1 a1hp actions a 1 a 1 h p after a 1 a 1 h p taking a 1 a 1 h p these a 1 a 1 h p medications. a 1
a 1 h p Enteric-coated a 1 a 1 h p tablets a 1 a 1 h p should a 1 a 1 h p not a 1 a 1 h p be a 1 a 1 h p crushed a 1 a 1 h p or a1 a1hp chewed,
a 1 a 1 h p which a 1 a 1 h p would a 1 a 1 h p alter a1 a1hp the a1 a1hp time a 1 a 1 h p and a 1 a 1 h p location a1 a1hp of a1 a1hp absorption. a 1
a 1 h p Acidic a 1 a 1 h p foods a1 a1hp will not
a1 a1hp a1 a1hp enhance a 1 a 1 h p the a 1 a 1 h p absorption a 1 a 1 h p of a 1 a 1 h p the a 1
a 1 h p medication. a 1 a 1 h p The a 1 a 1 h p patient a 1 a 1 h p should a 1 a 1 h p not a 1 a 1 h p to a 1 a 1 h p eat a 1 a 1 h p high-fat a 1
a 1 h p food a1 a1hp before a 1 a 1 h p ingesting a 1 a 1 h p an a 1 a 1 h p enteric-coated a 1 a 1 h p tablet, a 1 a 1 h p because a 1
a 1 h p high-fat a 1 a 1 h p foods a 1 a 1 h p decrease a 1 a 1 h p the a 1 a 1 h p absorption a1 a1hp rate.
DIF: COGNITIVE a1a1hp a1 a1hp LEVEL: a 1 a 1 h p Applying a 1 a 1 h p (Application) a 1
a 1 h p REF: a 1 a 1 h p dm a 1 a 1 h p 3 a1 a1hp TOP: a 1 a 1 h p NURSING a 1 a 1 h p PROCESS: a 1
a 1 h p Nursing a 1 a 1 h p Intervention
MSC: NCLEX: a1a1hp a1 a1hp Physiological a1 a1 hp Integrity: a1 a1hp Pharmacological a 1 a 1 h p and a 1 a 1 h p Parenteral a1
Therapies
a1hp
4. A a 1 a 1 h p patient a 1 a 1 h p who a 1 a 1 h p is a 1 a 1 h p newly a 1 a 1 h p diagnosed a 1 a 1 h p with a 1 a 1 h p type a 1 a 1 h p 1 a 1
a 1 h p diabetes a 1 a 1 h p mellitus a 1 a 1 h p asks a 1 a 1 h p why a 1 a 1 h p insulin a 1 a 1 h p must a1 a1hp be a1 a1hp given a1 a1hp by a1
a1hp subcutaneous a1 a1hp injection a1 a1hp instead a1 a1hp of a1 a1hp by mouth. a1 a1hp a1 a1hp The a1 a1hp nurse a1 a1hp will explain a1a1hp a1 a1hp that
a1 a1hp this a1 a1hp is a1 a1hp because
a. absorption a1 a1hp is a 1 a 1 h p diminished a 1 a 1 h p by the a1a1hp a1 a1hp first-pass a1 a1hp effects a1 a1hp in the a1 a1hp a 1
liver.
a1 hp
b. absorption a1 a1hp is a 1 a 1 h p faster a1 a1hp when a1 a1hp insulin a1 a1hp is a1 a1hp given a1 a1hp subcutaneously.
c. digestive a 1 a 1 hp enzymes a1 a1hp in a1 a1hp the a1 a1hp gastrointestinal tract a1a1hp a 1 a 1 h p prevent a 1 a 1 h p absorption.
d. the a1 a1hp oral a1 a1hp form is a1a1hp a 1 a 1 h p less a 1 a 1 h p predictable a1
Page 2
of
, with
a1hp a1 a1hp more a1 a1hp adverse a1 a1hp effects. a 1 a 1 h p ANS: a 1
a 1 h p C
Insulin, a 1 a 1 h p growth a 1 a 1 h p hormones, a 1 a 1 h p and a 1 a 1 h p other a1 a1hp protein-based a 1 a 1 h p drugs a1 a1hp are a1
a1hp destroyed a 1 a 1 h p in a1 a 1 hp the a1 a1hp small a1 a1hp intestine a1 a1hp by a 1 a 1 h p digestive a 1 a 1 h p enzymes a 1
a 1 h p and a 1 a 1 h p must a 1 a 1 h p be a 1 a 1 h p given a 1 a 1 h p parenterally. a 1 a 1 h p Because a 1 a 1 h p insulin a 1 a 1 h p is a 1
a 1 h p destroyed a 1 a 1 h p by a1 a1hp digestive a 1 a 1 h p enzymes, a 1 a 1 h p it a 1 a 1 h p would a 1 a 1 h p not a 1 a 1 h p make a1
a1hp it a 1 a 1 h p to a 1 a 1 h p the a1 a1hp liver a1 a1hp for a1 a1hp metabolism a 1 a 1 h p with a a1a1hp a1 a1hp first-pass a 1 a 1 h p effect. a1
Subcutaneous
a1hp a 1 a 1 h p tissue a 1 a 1 h p has a 1 a 1 h p fewer a 1 a 1 h p blood a 1 a 1 h p vessels, a 1 a 1 h p so a 1
a 1 h p absorption a 1 a 1 h p is a 1 a 1 h p slower a 1 a 1 h p in a 1 a 1 h p such a 1 a 1 h p tissue.
Insulin a 1 a 1 h p is a 1 a 1 h p given a 1 a 1 h p subcutaneously a 1 a 1 h p because a 1 a 1 h p it a 1 a 1 h p is a 1 a 1 h p desirable a 1 a 1 h p to a 1
have
a 1 h p a 1 a 1 h p it a 1 a 1 h p absorb a 1 a 1 h p slowly.
DIF: COGNITIVE
a1a1hp a1 a1hp LEVEL: Understanding a1a1hp a 1 a 1 h p (Comprehension) a 1
a 1 h p REF: a 1 a 1 h p dm a 1 a 1 h p 3 a1 a1hp TOP: a 1 a 1 h p NURSING a 1 a 1 h p PROCESS: a 1
a 1 h p Nursing a 1 a 1 h p Intervention: a 1 a 1 h p Patient a 1 a 1 h p Teaching
Page 3
of
a1 a1 a1 a1 a1 a1 a1 a1 a1
a1 Karen Whalen||ISBN NO:10,1975170555||ISBN NO:13,978-
a1 a1 a1
1975170554||Chapter 1-48||Complete Guide A+.
a1 a1 a1
hp 1
,
,3. The a 1 a 1 h p nurse a1 a1hp is a 1 a 1 h p teaching a1 a1hp a a1 a1hp patient a 1 a 1 h p who a1 a1hp will a1 a1hp be a1 a1hp discharged a 1
a 1 h p home a1 a1hp with a a1 a1hp a1 a1hp prescription a1 a1hp for a1 a1hp an a1 a1hp enteric- a 1 a 1 h p coated a 1 a 1 h p tablet. a 1
a 1 h p Which a 1 a 1 h p statement a 1 a 1 h p by a1 a1hp the a 1 a 1 h p patient indicates a 1 a 1 h p understanding a 1
a 1 h p of a 1 a 1 h p the a1 a1hp teaching?
a. I may y7crush the tablet
a1 a1hp a1 a1hp a1 a1hp a 1 a 1 h p and a 1 a 1 h p put a 1 a 1 h p it a 1 a 1 h p in applesauce
a1 a1hp a1 a1hp to a1
improve
a1hp absorption. a1 a1hp
b. I a 1 a 1 h p should consume a 1 a 1 h p a 1 a 1 hp acidic a 1 a 1 h p foods to y7 a 1 a 1 h p enhance a1 a1hp absorption a 1 a 1 h p of a1
a1hp this a1 a1hpmedication.
c. I a 1 should
a 1 h p a 1 a 1 h p expect a 1 a 1 h p a a 1 a 1 h p delay a 1 a 1 h p in onset
a 1 a 1 h p a 1 a 1 h p of a 1 a 1 h p the a 1
a 1 h p drugs effects a 1 a 1 h p a 1 after
a 1 h p a 1 a 1 h p taking a 1 the
a 1 h p a 1 a 1 h p tablet.
d. I should
a1 a1hp a 1 a 1 h p take this medication with high-fat
a1 a1hp a1 a1hp a 1 a 1 h p a1 a1hp a 1
a 1 h p foods to a1a1hp a 1 a 1 hp improve its action. ANS: C a1 a1hp a1 a1hp a 1 a 1 h p a 1 a 1 h p
Enteric-coated a 1 a 1 h p tablets a 1 a 1 h p resist a 1 a 1 h p disintegration a 1 a 1 h p in a 1 a 1 h p the a 1 a 1 h p acidic a 1
a 1 h p environment a 1 a 1 h p of a 1 a 1 h p the a 1 a 1 h p stomach a 1 a 1 h p and a1 a1hp disintegrate a1 a1hp when a1 a1hp they a1
a1hp reach a1 a1hp the a1 a1hp small a 1 a 1 h p intestine. a1 a1hp There a 1 a 1 h p is a 1 a 1 h p usually a 1 a 1 h p some a 1 a 1 h p delay a1
a1hp in a1 a1hp onset a 1 a 1 h p of a1 a1hp actions a 1 a 1 h p after a 1 a 1 h p taking a 1 a 1 h p these a 1 a 1 h p medications. a 1
a 1 h p Enteric-coated a 1 a 1 h p tablets a 1 a 1 h p should a 1 a 1 h p not a 1 a 1 h p be a 1 a 1 h p crushed a 1 a 1 h p or a1 a1hp chewed,
a 1 a 1 h p which a 1 a 1 h p would a 1 a 1 h p alter a1 a1hp the a1 a1hp time a 1 a 1 h p and a 1 a 1 h p location a1 a1hp of a1 a1hp absorption. a 1
a 1 h p Acidic a 1 a 1 h p foods a1 a1hp will not
a1 a1hp a1 a1hp enhance a 1 a 1 h p the a 1 a 1 h p absorption a 1 a 1 h p of a 1 a 1 h p the a 1
a 1 h p medication. a 1 a 1 h p The a 1 a 1 h p patient a 1 a 1 h p should a 1 a 1 h p not a 1 a 1 h p to a 1 a 1 h p eat a 1 a 1 h p high-fat a 1
a 1 h p food a1 a1hp before a 1 a 1 h p ingesting a 1 a 1 h p an a 1 a 1 h p enteric-coated a 1 a 1 h p tablet, a 1 a 1 h p because a 1
a 1 h p high-fat a 1 a 1 h p foods a 1 a 1 h p decrease a 1 a 1 h p the a 1 a 1 h p absorption a1 a1hp rate.
DIF: COGNITIVE a1a1hp a1 a1hp LEVEL: a 1 a 1 h p Applying a 1 a 1 h p (Application) a 1
a 1 h p REF: a 1 a 1 h p dm a 1 a 1 h p 3 a1 a1hp TOP: a 1 a 1 h p NURSING a 1 a 1 h p PROCESS: a 1
a 1 h p Nursing a 1 a 1 h p Intervention
MSC: NCLEX: a1a1hp a1 a1hp Physiological a1 a1 hp Integrity: a1 a1hp Pharmacological a 1 a 1 h p and a 1 a 1 h p Parenteral a1
Therapies
a1hp
4. A a 1 a 1 h p patient a 1 a 1 h p who a 1 a 1 h p is a 1 a 1 h p newly a 1 a 1 h p diagnosed a 1 a 1 h p with a 1 a 1 h p type a 1 a 1 h p 1 a 1
a 1 h p diabetes a 1 a 1 h p mellitus a 1 a 1 h p asks a 1 a 1 h p why a 1 a 1 h p insulin a 1 a 1 h p must a1 a1hp be a1 a1hp given a1 a1hp by a1
a1hp subcutaneous a1 a1hp injection a1 a1hp instead a1 a1hp of a1 a1hp by mouth. a1 a1hp a1 a1hp The a1 a1hp nurse a1 a1hp will explain a1a1hp a1 a1hp that
a1 a1hp this a1 a1hp is a1 a1hp because
a. absorption a1 a1hp is a 1 a 1 h p diminished a 1 a 1 h p by the a1a1hp a1 a1hp first-pass a1 a1hp effects a1 a1hp in the a1 a1hp a 1
liver.
a1 hp
b. absorption a1 a1hp is a 1 a 1 h p faster a1 a1hp when a1 a1hp insulin a1 a1hp is a1 a1hp given a1 a1hp subcutaneously.
c. digestive a 1 a 1 hp enzymes a1 a1hp in a1 a1hp the a1 a1hp gastrointestinal tract a1a1hp a 1 a 1 h p prevent a 1 a 1 h p absorption.
d. the a1 a1hp oral a1 a1hp form is a1a1hp a 1 a 1 h p less a 1 a 1 h p predictable a1
Page 2
of
, with
a1hp a1 a1hp more a1 a1hp adverse a1 a1hp effects. a 1 a 1 h p ANS: a 1
a 1 h p C
Insulin, a 1 a 1 h p growth a 1 a 1 h p hormones, a 1 a 1 h p and a 1 a 1 h p other a1 a1hp protein-based a 1 a 1 h p drugs a1 a1hp are a1
a1hp destroyed a 1 a 1 h p in a1 a 1 hp the a1 a1hp small a1 a1hp intestine a1 a1hp by a 1 a 1 h p digestive a 1 a 1 h p enzymes a 1
a 1 h p and a 1 a 1 h p must a 1 a 1 h p be a 1 a 1 h p given a 1 a 1 h p parenterally. a 1 a 1 h p Because a 1 a 1 h p insulin a 1 a 1 h p is a 1
a 1 h p destroyed a 1 a 1 h p by a1 a1hp digestive a 1 a 1 h p enzymes, a 1 a 1 h p it a 1 a 1 h p would a 1 a 1 h p not a 1 a 1 h p make a1
a1hp it a 1 a 1 h p to a 1 a 1 h p the a1 a1hp liver a1 a1hp for a1 a1hp metabolism a 1 a 1 h p with a a1a1hp a1 a1hp first-pass a 1 a 1 h p effect. a1
Subcutaneous
a1hp a 1 a 1 h p tissue a 1 a 1 h p has a 1 a 1 h p fewer a 1 a 1 h p blood a 1 a 1 h p vessels, a 1 a 1 h p so a 1
a 1 h p absorption a 1 a 1 h p is a 1 a 1 h p slower a 1 a 1 h p in a 1 a 1 h p such a 1 a 1 h p tissue.
Insulin a 1 a 1 h p is a 1 a 1 h p given a 1 a 1 h p subcutaneously a 1 a 1 h p because a 1 a 1 h p it a 1 a 1 h p is a 1 a 1 h p desirable a 1 a 1 h p to a 1
have
a 1 h p a 1 a 1 h p it a 1 a 1 h p absorb a 1 a 1 h p slowly.
DIF: COGNITIVE
a1a1hp a1 a1hp LEVEL: Understanding a1a1hp a 1 a 1 h p (Comprehension) a 1
a 1 h p REF: a 1 a 1 h p dm a 1 a 1 h p 3 a1 a1hp TOP: a 1 a 1 h p NURSING a 1 a 1 h p PROCESS: a 1
a 1 h p Nursing a 1 a 1 h p Intervention: a 1 a 1 h p Patient a 1 a 1 h p Teaching
Page 3
of